Results 31 to 40 of about 5,969 (169)

Evaluasi Kesesuaian Penulisan Resep pada Kasus ISPA Non Pneumonia di Poli MTBS Puskesmas Kecamatan Cengkareng [PDF]

open access: yes, 2017
Acute respiratory infections (ARI) is one of the major health problems in Indonesia. There are three classifications of cases of ARI, consist of pneumonia, severe pneumonia and non pneumonia. This study aimed to find an overview of the use of antibiotics
Aulia, A. A. (Annisa)   +2 more
core   +2 more sources

Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers

open access: yesPulmonary Therapy, 2020
Plain Language Summary Ambroxol is used to relieve the symptoms of respiratory conditions in which abnormal mucus secretion is a problem, including the common cold, acute and chronic bronchitis, and chronic obstructive pulmonary disease.
Celine Ollier   +3 more
doaj   +1 more source

Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method

open access: yesРазработка и регистрация лекарственных средств, 2019
Introduction. Multicomponent oral drugs containing salbutamol, bromhexine, ambroxol and guaifenesin have a mucolytic, expectorant and bronchodilator effect.
T. N. Komarov   +7 more
doaj   +1 more source

Analysis of the evidence of efficacy and safety of over-the-counter cough medications registered in Brazil [PDF]

open access: yes, 2010
The objective of this study was to analyze the level of evidence regarding the efficacy, effectiveness and safety of over-the-counter (OTC) cough medications registered in Brazil.
FIGUERAS, Albert   +1 more
core   +4 more sources

Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells

open access: yesNeurobiology of Disease, 2015
Heterozygous mutations in GBA1 gene, encoding for lysosomal enzyme glucocerebrosidase (GCase), are a major risk factor for sporadic Parkinson's disease (PD).
Giulia Ambrosi   +5 more
doaj   +1 more source

Therapy in Bronchopulmonary Diseases Associated with Increased Secretion of Viscous Sputum and Impaired Mucus Transport

open access: yesZdorovʹe Rebenka, 2015
The article deals with the problem of cough in bronchopulmonary diseases, in particular, the attention is paid to cough with increased secretion of viscous sputum, i.e., productive cough.
Yu.V. Marushko, M.H. Hrachova
doaj   +1 more source

Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential [PDF]

open access: yes, 2015
Autophagy is a conserved homeostatic process active in all human cells and affecting a spectrum of diseases. Here we use a pharmaceutical screen to discover new mechanisms for activation of autophagy.
Ahmed, Zahra   +16 more
core   +3 more sources

Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database [PDF]

open access: yes, 2017
Background Few studies on the causes of drug-induced anaphylaxis (DIA) in the hospital setting are available. Objective We aimed to use the Beijing Pharmacovigilance Database (BPD) to identify the causes of DIA in Beijing, China.
Li, Xiaotong   +7 more
core   +1 more source

The use of ambroxol in various fields of medicine outside medical indications - A Review of the Current Literature

open access: yesQuality in Sport
Introduction: Ambroxol is a drug that has a multifaceted application in medicine. Its main effects are mucolytic, mucokinetic, anti-inflammatory, antioxidant and local anesthetic.
Alicja Czyszczoń   +9 more
doaj   +1 more source

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ambroxol Hard-Boiled Lozenges in Patients with Acute Pharyngitis

open access: yesPulmonary Therapy, 2019
Introduction The aim of this study was to evaluate the efficacy and safety of a new hard-boiled lozenge formulation containing ambroxol 20 mg versus placebo for the relief of sore throat in patients with acute pharyngitis.
Rita Sousa   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy